Cargando…

Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England

BACKGROUND: Hospital decision-makers have limited resources to implement quality improvement projects. To decide which interventions to take forward, trade-offs must be considered that inevitably turn on stakeholder preferences. The multi-criteria decision analysis (MCDA) approach could make this de...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanal, Saval, Schmidtke, Kelly Ann, Talat, Usman, Turner, Alice M., Vlaev, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318338/
https://www.ncbi.nlm.nih.gov/pubmed/37409178
http://dx.doi.org/10.3389/frhs.2023.1155523
_version_ 1785068015343108096
author Khanal, Saval
Schmidtke, Kelly Ann
Talat, Usman
Turner, Alice M.
Vlaev, Ivo
author_facet Khanal, Saval
Schmidtke, Kelly Ann
Talat, Usman
Turner, Alice M.
Vlaev, Ivo
author_sort Khanal, Saval
collection PubMed
description BACKGROUND: Hospital decision-makers have limited resources to implement quality improvement projects. To decide which interventions to take forward, trade-offs must be considered that inevitably turn on stakeholder preferences. The multi-criteria decision analysis (MCDA) approach could make this decision process more transparent. METHOD: An MCDA was conducted to rank-order four types of interventions that could optimise medication use in England's National Healthcare System (NHS) hospitals, including Computerised Interface, Built Environment, Written Communication, and Face-to-Face Interactions. Initially, a core group of quality improvers (N = 10) was convened to determine criteria that could influence which interventions are taken forward according to the Consolidated Framework for Implementation Research. Next, to determine preference weightings, a preference survey was conducted with a diverse group of quality improvers (N = 356) according to the Potentially All Pairwise Ranking of All Possible Alternatives method. Then, rank orders of four intervention types were calculated according to models with criteria unweighted and weighted according to participant preferences using an additive function. Uncertainty was estimated by probabilistic sensitivity analysis using 1,000 Monte Carlo Simulation iterations. RESULTS: The most important criteria influencing what interventions were preferred was whether they addressed “patient needs” (17.6%)' and their financial “cost (11.5%)”. The interventions' total scores (unweighted score out of 30 | weighted out of 100%) were: Computerised Interface (25 | 83.8%), Built Environment (24 | 79.6%), Written Communication (22 | 71.6%), and Face-to-Face (22 | 67.8%). The probabilistic sensitivity analysis revealed that the Computerised Interface would be the most preferred intervention over various degrees of uncertainty. CONCLUSIONS: An MCDA was conducted to rank order intervention types that stand to increase medication optimisation across hospitals in England. The top-ranked intervention type was the Computerised Interface. This finding does not imply Computerised Interface interventions are the most effective interventions but suggests that successfully implementing lower-ranked interventions may require more conversations that acknowledge stakeholder concerns.
format Online
Article
Text
id pubmed-10318338
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103183382023-07-05 Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England Khanal, Saval Schmidtke, Kelly Ann Talat, Usman Turner, Alice M. Vlaev, Ivo Front Health Serv Health Services BACKGROUND: Hospital decision-makers have limited resources to implement quality improvement projects. To decide which interventions to take forward, trade-offs must be considered that inevitably turn on stakeholder preferences. The multi-criteria decision analysis (MCDA) approach could make this decision process more transparent. METHOD: An MCDA was conducted to rank-order four types of interventions that could optimise medication use in England's National Healthcare System (NHS) hospitals, including Computerised Interface, Built Environment, Written Communication, and Face-to-Face Interactions. Initially, a core group of quality improvers (N = 10) was convened to determine criteria that could influence which interventions are taken forward according to the Consolidated Framework for Implementation Research. Next, to determine preference weightings, a preference survey was conducted with a diverse group of quality improvers (N = 356) according to the Potentially All Pairwise Ranking of All Possible Alternatives method. Then, rank orders of four intervention types were calculated according to models with criteria unweighted and weighted according to participant preferences using an additive function. Uncertainty was estimated by probabilistic sensitivity analysis using 1,000 Monte Carlo Simulation iterations. RESULTS: The most important criteria influencing what interventions were preferred was whether they addressed “patient needs” (17.6%)' and their financial “cost (11.5%)”. The interventions' total scores (unweighted score out of 30 | weighted out of 100%) were: Computerised Interface (25 | 83.8%), Built Environment (24 | 79.6%), Written Communication (22 | 71.6%), and Face-to-Face (22 | 67.8%). The probabilistic sensitivity analysis revealed that the Computerised Interface would be the most preferred intervention over various degrees of uncertainty. CONCLUSIONS: An MCDA was conducted to rank order intervention types that stand to increase medication optimisation across hospitals in England. The top-ranked intervention type was the Computerised Interface. This finding does not imply Computerised Interface interventions are the most effective interventions but suggests that successfully implementing lower-ranked interventions may require more conversations that acknowledge stakeholder concerns. Frontiers Media S.A. 2023-06-20 /pmc/articles/PMC10318338/ /pubmed/37409178 http://dx.doi.org/10.3389/frhs.2023.1155523 Text en © 2023 Khanal, Schmidtke, Talat, Turner and Vlaev. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Health Services
Khanal, Saval
Schmidtke, Kelly Ann
Talat, Usman
Turner, Alice M.
Vlaev, Ivo
Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
title Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
title_full Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
title_fullStr Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
title_full_unstemmed Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
title_short Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
title_sort using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in england
topic Health Services
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318338/
https://www.ncbi.nlm.nih.gov/pubmed/37409178
http://dx.doi.org/10.3389/frhs.2023.1155523
work_keys_str_mv AT khanalsaval usingmulticriteriadecisionanalysistodescribestakeholderpreferencesfornewqualityimprovementinitiativesthatcouldoptimiseprescribinginengland
AT schmidtkekellyann usingmulticriteriadecisionanalysistodescribestakeholderpreferencesfornewqualityimprovementinitiativesthatcouldoptimiseprescribinginengland
AT talatusman usingmulticriteriadecisionanalysistodescribestakeholderpreferencesfornewqualityimprovementinitiativesthatcouldoptimiseprescribinginengland
AT turneralicem usingmulticriteriadecisionanalysistodescribestakeholderpreferencesfornewqualityimprovementinitiativesthatcouldoptimiseprescribinginengland
AT vlaevivo usingmulticriteriadecisionanalysistodescribestakeholderpreferencesfornewqualityimprovementinitiativesthatcouldoptimiseprescribinginengland